DTIL – Precision BioSciences, Inc.
DTIL
$4.27Name : Precision BioSciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $47,321,112.00
EPSttm : -2.87
Precision BioSciences, Inc.
$4.27
Float Short %
6.73
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.03
EPS Last/This Y
-9.79
EPS This/Next Y
1.2
Price
4.32
Target Price
30.5
Analyst Recom
1
Performance Q
-5.29
Relative Volume
1.38
Beta
1.44
Ticker: DTIL
19 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-06-02 | DTIL | 5.04 | N/A | N/A | 0 |
2025-06-03 | DTIL | 5.1 | N/A | N/A | 0 |
2025-06-04 | DTIL | 5.15 | N/A | N/A | 0 |
2025-06-05 | DTIL | 5.19 | N/A | N/A | 0 |
2025-06-06 | DTIL | 5.27 | N/A | N/A | 0 |
2025-06-09 | DTIL | 5.31 | N/A | N/A | 0 |
2025-06-10 | DTIL | 5.24 | N/A | N/A | 0 |
2025-06-11 | DTIL | 5.07 | N/A | N/A | 0 |
2025-06-12 | DTIL | 5.01 | N/A | N/A | 0 |
2025-06-13 | DTIL | 4.9 | N/A | N/A | 0 |
2025-06-16 | DTIL | 5.13 | N/A | N/A | 0 |
2025-06-17 | DTIL | 4.9 | N/A | N/A | 0 |
2025-06-18 | DTIL | 4.7 | N/A | N/A | 0 |
2025-06-20 | DTIL | 4.76 | N/A | N/A | 0 |
2025-06-23 | DTIL | 4.55 | N/A | N/A | 0 |
2025-06-24 | DTIL | 4.6 | N/A | N/A | 0 |
2025-06-25 | DTIL | 4.22 | N/A | N/A | 0 |
2025-06-26 | DTIL | 4.15 | N/A | N/A | 0 |
2025-06-27 | DTIL | 4.29 | N/A | N/A | 0 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-06-02 | DTIL | 5.03 | -147.2 | - | -8.74 |
2025-06-03 | DTIL | 5.15 | -147.2 | - | -8.74 |
2025-06-04 | DTIL | 5.16 | -147.2 | - | -8.74 |
2025-06-05 | DTIL | 5.13 | -147.2 | - | -8.74 |
2025-06-06 | DTIL | 5.39 | -147.2 | - | -8.74 |
2025-06-09 | DTIL | 5.30 | -147.2 | - | -8.74 |
2025-06-10 | DTIL | 5.29 | -147.2 | - | -8.74 |
2025-06-11 | DTIL | 5.15 | -147.2 | - | -8.74 |
2025-06-12 | DTIL | 5.03 | -147.2 | - | -8.74 |
2025-06-13 | DTIL | 4.90 | -147.2 | - | -8.74 |
2025-06-16 | DTIL | 5.12 | -147.2 | - | -8.74 |
2025-06-17 | DTIL | 4.90 | -147.2 | - | -8.74 |
2025-06-18 | DTIL | 4.70 | -147.2 | - | -8.74 |
2025-06-20 | DTIL | 4.79 | -147.2 | - | -8.74 |
2025-06-23 | DTIL | 4.61 | -147.2 | - | -8.74 |
2025-06-24 | DTIL | 4.59 | -147.2 | - | -8.74 |
2025-06-25 | DTIL | 4.22 | -147.2 | - | -8.74 |
2025-06-26 | DTIL | 4.16 | -147.2 | - | -8.74 |
2025-06-27 | DTIL | 4.32 | -147.2 | - | -8.74 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
19 items
«
‹
Current Page1 of 1
›
»
18 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-06-02 | DTIL | -1.16 | 11.67 | 21.76 |
2025-06-03 | DTIL | -1.16 | 11.67 | 21.76 |
2025-06-04 | DTIL | -1.16 | 11.67 | 21.76 |
2025-06-05 | DTIL | -1.16 | 11.67 | 21.76 |
2025-06-06 | DTIL | -1.16 | 11.67 | 21.76 |
2025-06-09 | DTIL | -1.16 | 12.42 | 21.76 |
2025-06-10 | DTIL | -1.16 | 12.42 | 21.76 |
2025-06-11 | DTIL | -1.16 | 12.42 | 19.23 |
2025-06-12 | DTIL | -1.16 | 12.42 | 19.23 |
2025-06-13 | DTIL | -1.16 | 12.42 | 19.23 |
2025-06-16 | DTIL | -1.16 | 12.42 | 19.23 |
2025-06-18 | DTIL | -1.16 | 12.42 | 19.23 |
2025-06-20 | DTIL | -1.16 | 12.42 | 19.23 |
2025-06-23 | DTIL | -1.16 | 12.42 | 19.23 |
2025-06-24 | DTIL | -1.16 | 12.42 | 19.23 |
2025-06-25 | DTIL | -1.16 | 12.42 | 19.23 |
2025-06-26 | DTIL | -1.16 | 12.42 | 6.73 |
2025-06-27 | DTIL | -0.93 | 12.42 | 6.73 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
18 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-2.21
Avg. EPS Est. Current Quarter
-2.21
Avg. EPS Est. Next Quarter
-2.24
Insider Transactions
-0.93
Institutional Transactions
12.42
Beta
1.44
Average Sales Estimate Current Quarter
6
Average Sales Estimate Next Quarter
5
Fair Value
Quality Score
28
Growth Score
40
Sentiment Score
18
Actual DrawDown %
99.1
Max Drawdown 5-Year %
-99.2
Target Price
30.5
P/E
Forward P/E
PEG
P/S
0.93
P/B
0.92
P/Free Cash Flow
EPS
-2.01
Average EPS Est. Cur. Y
-8.74
EPS Next Y. (Est.)
-7.55
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-42.99
Relative Volume
1.38
Return on Equity vs Sector %
-68.5
Return on Equity vs Industry %
-50.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 107
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
stock quote shares DTIL – Precision BioSciences, Inc. Stock Price stock today
news today DTIL – Precision BioSciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DTIL – Precision BioSciences, Inc. yahoo finance google finance
stock history DTIL – Precision BioSciences, Inc. invest stock market
stock prices DTIL premarket after hours
ticker DTIL fair value insiders trading